MedMe Health (YC W21)

MedMe Health (YC W21)

MedMe is on a mission to revolutionize the role of pharmacies by transforming them into integrated community health hubs. The startup has developed an all-in-one cloud-based platform that enables pharmacists to efficiently schedule, document, and manage clinical services at scale. It has successfully partnered with the two largest pharmacy chains in Canada, serving over 3000 pharmacies and facilitating more than 14M patient services, notably contributing during the pandemic.

The company has secured over $3.7M USD in funding, with support from notable backers such as M12 (Microsoft’s Venture Fund), MaRS IAF, and Y-Combinator. The recent investment of $3.40M Seed Round on 17 March 2022, with participation from Y Combinator, MaRS IAF, M12, and Graphite Ventures, underscores investor confidence in the startup's potential.

Established in 2019, MedMe Health operates within the B2B and Health Care sectors, with its headquarters based in Canada. With a focus on expanding its platform, the company is in a strong position to provide comprehensive, accessible healthcare offerings and elevate the quality of care experiences for patients. As MedMe continues to grow across various functions including Engineering, Customer Success, and Product development, it presents an appealing opportunity for potential investors seeking to tap into the innovative healthcare technology space.